Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001800030 | SCV002044106 | uncertain significance | not provided | 2022-03-10 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV002541333 | SCV003476441 | likely benign | Kabuki syndrome 2 | 2022-06-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004988752 | SCV005612965 | likely benign | Inborn genetic diseases | 2024-11-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002541333 | SCV005682917 | uncertain significance | Kabuki syndrome 2 | 2024-06-07 | criteria provided, single submitter | clinical testing |